Related Experiment Video
Updated: May 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Life years lost due to cardiovascular diseases
Irena Maniecka-Bryła1, Małgorzata Pikala, Marek Bryła
1Department of Epidemiology and Biostatistics, Medical University of Lodz, Lodz, Poland. irena.maniecka-bryla@umed.lodz.pl.
Insights
Cardiovascular disease (CVD) significantly impacts life expectancy, causing substantial years of life lost. Ischaemic heart disease (IHD) and cerebrovascular disease were major contributors in the Lodz region, with concerning trends observed.
Area of Science:
- Public Health
- Epidemiology
- Cardiology
Background:
- Premature mortality measures, such as years of life lost, are crucial for population health assessment.
- Cardiovascular diseases (CVD) represent a leading cause of premature death and significant loss of life years.
Purpose of the Study:
- To quantify life years lost due to CVD in the Lodz region.
- To identify specific CVDs causing the most life years lost and analyze trends from 1999-2008.
Main Methods:
- Analysis of 146,852 CVD-related death certificates from the Lodz region (1999-2008).
- Calculation of Standard Expected Years of Life Lost per person (SEYLLp) and per death (SEYLLd).
- Application of Joinpoint models to analyze temporal trends and estimate average annual percentage changes.
Main Results:
- In 2008, life years lost were 754/10,000 males and 595/10,000 females.
- Males: Ischaemic heart disease (IHD) (SEYLLp=200), particularly acute myocardial infarction (AMI) (SEYLLp=128), and other heart diseases (SEYLLp=199) were primary causes.
- Females: Cerebrovascular disease (SEYLLp=176) and other heart diseases (SEYLLp=152) were the leading causes of life years lost.
Conclusions:
- IHD was the leading cause of life years lost in males, while cerebrovascular disease predominated in females.
- An increasing trend in CVD-related life years lost was observed from 2002/2003, decelerating after 2006.
- IHD showed the most significant decrease in life years lost for both sexes between 1999 and 2008.
Background:
When evaluating the health status of a population, an increasingly important role is played by measures aiming to access premature mortality in lost lifetime units. There is a considerable number of life years 'to be recovered' provided cardiovascular disease (CVD) mortality is reduced, as CVD cause the highest absolute number of years lost.
Aim:
To access life years lost by the inhabitants of the Lodz region due to CVD and to determine the rank of each disorder within this ICD-10 class, which causes most life years lost, as well as to identify trends in this regard.
Methods:
Our research was based on a dataset consisting of 313,144 death certificates, including 146,852 due to CVD, of the inhabitants of the Lodz region from 1999 to 2008. We applied the standard expected years of life lost (SEYLL) indicators per living person (SEYLLp) and per death (SEYLLd) to calculate life years lost. Joinpoint models were used to analyse changes in time. We also estimated average annual percentage changes in the SEYLL indicators.
Results:
In 2008, the number of life years lost amounted to 754 per 10,000 males and 595 per 10,000 females. The most important contribution to life years lost among males was from ischaemic heart disease (IHD) (SEYLLp = 200), particularly acute myocardial infarction (AMI) (SEYLLp = 128). Nearly the same number of years lost was due to other heart disease (SEYLLp = 199), especially heart failure (SEYLLp = 121). Cerebrovascular disease caused 191 life years lost per 10,000 males, while diseases of arteries, arterioles and capillaries caused the loss of 98 life years per 10,000 males. In women, the highest number of life years lost was attributed to cerebrovascular disease (SEYLLp = 176) and other heart disease (SEYLLp = 152), especially heart failure (SEYLLp = 95). IHD contributed to the loss of 113 life years per 10,000 females (including AMI: SEYLLp = 62), while diseases of arteries, arterioles and capillaries led to 112 life years lost per 10,000 females.
Conclusions:
The highest number of life years lost resulted from IHD among males and cerebrovascular disease among females. A growing trend in the number of life years lost due to CVD was noted since 2002 for males and since 2003 for females. These unfavourable trends decelerated considerably after 2006. The highest decrease in life years lost for both sexes in 1999-2008 was noted for IHD.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease III: Clinical Manifestations